|
1. Lee, S.-S.; Tseng, C.-C.; Chen, C.-K., Three new benzophenone glucosides from the leaves of Planchonella obovata. Helvetica Chimica Acta 2010, 93, 522-529. 2. Chen, H.-Y. Chemical investigation of the leaves of Planchonella obovata (R. Br.) Pierre (II). Master Thesis, National Taiwan University, 2011. 3. Huang, T. C.; Hsieh, T. H.; Cheng, W. T., Flora of Taiwan. 2nd ed.; Editorial committee of the Flora of Taiwan: Taipei, 1996; Vol. IV, p 83-87. 4. Cambie, R. C.; Ser, N. A.; Kokubun, T., Heartwood constituents of Planchonella vitiensis. Biochemical Systematics and Ecology 1997, 25, 677-678. 5. Eade, R. A.; Hunt, K.; Simes, J. J. H.; Stern, W., Extractives of Australian timbers. IX. The saponin of Planchonella pohlmanianum. Australian Journal of Chemistry 1969, 22, 2703-2707. 6. Lee, T. H.; Juang, S. H.; Hsu, F. L., Triterpene acids from the leaves of Planchonella duclitan (Blanco) Bakhuizan. Journal of the Chinese Chemical Society 2005, 52, 1275-1280. 7. Hart, N. K.; Johns, S. R.; Lamber, J. A., Alkaloids of the Sapotaceae: trans-β-methylthioacrylate and tiglate esters of (−)-isoretronecanol from a Planchonella species. Australian Journal of Chemistry 1968, 21, 1393-1395. 8. Hart, N.; Lamberton, J., Pyrrolizidine alkaloids from Planchonella species (family Sapotaceae). Australian Journal of Chemistry 1966, 19, 1259-1264. 9. 臺灣衛生福利部統計處 105年國人死因統計結果分析. http://www.mohw.gov.tw/cp-16-33598-1.html. 10. Greaves, W. O.; Bueso-Ramos, C. E., Emerging cancer therapeutics: leukemia. Popat, U., Ed. Springer New York: New York, 2011; pp. 15-40. 11. Tallman, M. S.; Altman, J. K., How I treat acute promyelocytic leukemia. Blood 2009, 114, 5126-5135. 12. Coombs, C. C.; Tavakkoli, M.; Tallman, M. S., Acute promyelocytic leukemia: where did we start, where are we now, and the future. Blood Cancer Journal 2015, 5, e304. 13. Shustov, A. R., The treatment of adult acute lymphoblastic leukemia (ALL): risk stratification and strategies. In Leukemia and Related Disorders: Integrated Treatment Approaches, Estey, E. H.; Appelbaum, F. R., Eds. Springer New York: New York, 2012; pp 37-66. 14. Coveler, A.; Oehler, V. G., Chronic myeloid leukemia (CML). In Leukemia and related disorders: integrated treatment approaches, Estey, E. H.; Appelbaum, F. R., Eds. Springer New York: New York, 2012; pp 97-147. 15. Gutman, J. A.; Smith, K. M.; Pagel, J. M.; Pagel, J. M., Chronic lymphocytic leukemia (CLL). In Leukemia and related disorders: integrated treatment approaches, Estey, E. H.; Appelbaum, F. R., Eds. Springer New York: New York, 2012; pp 67-96. 16. Sanz, M. A.; Grimwade, D.; Tallman, M. S.; Lowenberg, B.; Fenaux, P.; Estey, E. H.; Naoe, T.; Lengfelder, E.; Büchner, T.; Döhner, H.; Burnett, A. K.; Lo-Coco, F., Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009, 113, 1875-1891. 17. Breccia, M.; Latagliata, R.; Carmosino, I.; Cannella, L.; Diverio, D.; Guarini, A.; De Propris, M. S.; Petti, M. C.; Avvisati, G.; Cimino, G.; Mandelli, F.; Lo-Coco, F., Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin. Haematologica 2008, 93, 1918-1920. 18. Chen, G.; Jin, H.; Li, X.; Zhang, Q.; Shen, Y.; Yan, S.; Zhang, W., Chemical constituents from Rhododendron spinuliferum. Chemistry of Natural Compounds 2009, 45, 725-727. 19. Ren, G.; Hou, J.; Fang, Q.; Sun, H.; Liu, X.; Zhang, L.; Wang, P. G., Synthesis of flavonol 3-O-glycoside by UGT78D1. Glycoconjugate Journal 2012, 29, 425-432. 20. Jiang, C.-L.; Tsai, S.-F.; Lee, S.-S., Flavonoids from Curcuma longa leaves and their NMR assignments. Natural Product Communications 2015, 10, 63-66. 21. Ohashi, K.; Watanabe, H.; Okumura, Y.; Uji, T.; Kitagawa, I., Indonesian medicinal plants. XII. Four isomaric lignan-glucosides from the bark of Aegle marmelos (Rutaceae). Chemical and Pharmaceutical Bulletin 1994, 42, 1924-1926. 22. Silva, V. C. d.; Silva, G. H.; Bolzani, V. d. S.; Lopes, M. N., Isolation of lignans glycosides from Alibertia sessilis (Vell.) K. Schum. (Rubiaceae) by preparative high-performance liquid chromatography. Eclética Química 2006, 31, 55-58. 23. Wen, Q.; Lin, X.; Liu, Y.; Xu, X.; Liang, T.; Zheng, N.; Kintoko; Huang, R., Phenolic and lignan glycosides from the butanol extract of Averrhoa carambola L. root. Molecules 2012, 17, 12330. 24. (a) Kasahara, H.; Jiao, Y.; Bedgar, D. L.; Kim, S.-J.; Patten, A. M.; Xia, Z.-Q.; Davin, L. B.; Lewis, N. G., Pinus taeda phenylpropenal double-bond reductase: purification, cDNA cloning, heterologous expression in Escherichia coli, and subcellular localization in P. taeda. Phytochemistry 2006, 67, 1765-1780; (b) Kuang, H.-X.; Xia, Y.-G.; Yang, B.-Y.; Wang, Q.-H.; Lü, S.-W., Lignan constituents from Chloranthus japonicus Sieb. Archives of Pharmacal Research 2009, 32, 329-334. 25. Shukla, Y. N.; Thakur, R. S.; Pachaly, P., A bidesmosidic oleanolic acid saponin from Panax pseudo-ginseng. Phytochemistry 1992, 31, 1046-1048. 26. Hara, S.; Okabe, H.; Mihashi, K., Gas-liquid chromatographic separation of aldose enantiomers as trimethylsilyl ethers of methyl 2-(polyhydroxyalkyl)-thiazolidi ne-4(R)-carboxylates. Chemical and Pharmaceutical Bulletin 1987, 35, 501-506. 27. Sargent, J. M.; Taylor, C. G., Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. British Journal of Cancer 1989, 60, 206-210. 28. Yuasa, K.; Ide, T.; Otsuka, H.; Ogimi, C.; Hirata, E.; Takushi, A.; Takeda, Y., Lignan and neolignan glycosides from stems of Alangium premnifolium. Phytochemistry 1997, 45, 611-615. 29. Park, C. H.; Kim, K. H.; Lee, I. K.; Lee, S. Y.; Choi, S. U.; Lee, J. H.; Lee, K. R., Phenolic constituents of Acorus gramineus. Archives of Pharmacal Research 2011, 34, 1289-1296. 30. Brasseur, T.; Angenot, L., Flavonol glycosides from leaves of Strychnos variabilis. Phytochemistry 1986, 25, 563-564. 31. (a) Zhang, J.; Kurita, M.; Shinozaki, T.; Ukiya, M.; Yasukawa, K.; Shimizu, N.; Tokuda, H.; Masters, E. T.; Akihisa, M.; Akihisa, T., Triterpene glycosides and other polar constituents of shea (Vitellaria paradoxa) kernels and their bioactivities. Phytochemistry 2014, 108, 157-170; (b) Chen, H.-Y.; Guh, J.-H.; Chan, S.-H.; Lee, S.-S., Cytotoxic protobassic acid glycosides from Planchonella obovata leaf. Phytochemistry Letters 2015, 11, 229-235. 32. Saha, S.; Walia, S.; Kumar, J.; Parmar, B. S., Structure-biological activity relationships in triterpenic saponins: the relative activity of protobassic acid and its derivatives against plant pathogenic fungi. Pest Management Science 2010, 66, 825-831. 33. Ragasa, C.; Torres, O.; Bernardo, L.; Madrazo, L.; Mandia, E.; Shen, C. C., Chemical constituents of Palaquium luzoniense. Chemistry of Natural Compounds 2015, 51, 181-182. 34. Gunasekera, S. P.; Kumar, V.; Sultanbawa, M. U. S.; Balasubramaniam, S., Triterpenoids and steroids of some Sapotaceae and their chemotaxonomic significance. Phytochemistry 1977, 16, 923-926. 35. Heilbron, I. M.; Kennedy, T.; Spring, F. S., 66. The unsaturated centre of the triterpene alcohol lupeol. Journal of the Chemical Society 1938, 329-334. 36. Siegel, R. L.; Miller, K. D.; Jemal, A., Cancer statistics, 2017. CA: A Cancer Journal for Clinicians 2017, 67, 7-30. 37. Huggins, C.; Hodges, C. V., Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research 1941, 1, 293-297. 38. Lorente, D.; Mateo, J.; Perez-Lopez, R.; de Bono, J. S.; Attard, G., Sequencing of agents in castration-resistant prostate cancer. The Lancet Oncology 2015, 16, e279-e292. 39. Litwin, M. S.; Tan, H., The diagnosis and treatment of prostate cancer: a review. The Journal of the American Medical Association 2017, 317, 2532-2542. 40. Kao, J.; Zucker, A.; Timmins, J.; Taramangalam, S.; Pettit, J.; Woodall, A. J.; Loizides, E.; Wong, A. T., Effect of modern, high-quality prostate intensity-modulated radiation therapy on outcome: Evidence from a community radiation oncology program. Molecular and Clinical Oncology 2017, 7, 252-258. 41. Leapman, M. S.; Carroll, P. R., What is the best way not to treat prostate cancer? Urologic Oncology: Seminars and Original Investigations 2017, 35, 42-50. 42. Francini, E.; Taplin, M.-E., Prostate cancer: developing novel approaches to castration-sensitive disease. Cancer 2017, 123, 29-42. 43. Harris, W. P.; Mostaghel, E. A.; Nelson, P. S.; Montgomery, B., Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nature Clinical Practice Urology 2009, 6, 76-85. 44. (a) Perlmutter, M. A.; Lepor, H., Androgen deprivation therapy in the treatment of advanced prostate cancer. Reviews in Urology 2007, 9, S3-S8; (b) Gunner, C.; Gulamhusein, A.; Rosario, D. J., The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer. Journal of Clinical Urology 2016, 9, 24-29. 45. West, T. A.; Kiely, B. E.; Stockler, M. R., Estimating scenarios for survival time in men starting systemic therapies for castration-resistant prostate cancer: a systematic review of randomised trials. European Journal of Cancer 2014, 50, 1916-1924. 46. (a) Petrylak, D. P.; Tangen, C. M.; Hussain, M. H. A.; Lara, P. N. J.; Jones, J. A.; Taplin, M. E.; Burch, P. A.; Berry, D.; Moinpour, C.; Kohli, M.; Benson, M. C.; Small, E. J.; Raghavan, D.; Crawford, E. D., Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N. Engl. J. Med. 2004, 351 (15), 1513-1520; (b) Tannock, I. F.; de Wit, R.; Berry, W. R.; Horti, J.; Pluzanska, A.; Chi, K. N.; Oudard, S.; Théodore, C.; James, N. D.; Turesson, I.; Rosenthal, M. A.; Eisenberger, M. A., Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. The New England Journal of Medicine 2004, 351, 1502-1512. 47. Shelley, M.; Harrison, C.; Coles, B.; Stafforth, J.; Wilt, T.; Mason, M., Chemotherapy for hormone-refractory prostate cancer. Cochrane Database of Systematic Reviews 2006. 48. Diamond, E.; del Carmen Garcias, M.; Karir, B.; Tagawa, S. T., The evolving role of cytotoxic chemotherapy in the management of patients with metastatic prostate cancer. Curr. Treat. Options Oncol. 2015, 16 (2), 9. 49. Nigam, S. K.; Li, X.-C.; Wang, D.-Z.; Misra, G.; Yang, C.-R., Triterpenoidal saponins from Madhuca butyracea. Phytochemistry 1992, 31, 3169-3172. 50. Charrouf, Z.; Wieruszeski, J. M.; Fkih-Tetouani, S.; Y, L.; Charrouf, M.; Fournet, B., Triterpenoid saponins from Argania spinosa. Phytochemistry 1992, 31, 2079-2086. 51. Lavaud, C.; Massiot, G.; Becchi, M.; Misra, G.; Nigam, S. K., Saponins from three species of Mimusops. Phytochemistry 1996, 41, 887-893. 52. Li, X.-C.; Liu, Y.-Q.; Wang, D.-Z.; Yang, C.-R.; Nigam, S. K.; Misra, G., Triterpenoid saponins from Madhuca butyracea. Phytochemistry 1994, 37, 827-829. 53. Eskander, J.; Lavaud, C.; Pouny, I.; Soliman, H. S. M.; Abdel-Khalik, S. M.; Mahmoud, I. I., Saponins from the seeds of Mimusops laurifolia. Phytochemistry 2006, 67, 1793-1799. 54. Alaoui, A.; Charrouf, Z.; Soufiaoui, M.; Carbone, V.; Malorni, A.; Pizza, C.; Piacente, S., Triterpenoid saponins from the shells of Argania spinosa seeds. Journal of Agricultural and Food Chemistry 2002, 50, 4600-4603. 55. Korver, O.; Wilkins, C. K., Circular dichroism spectra of flavanols. Tetrahedron 1971, 27, 5459-5465. 56. (a) Bilia, A. R.; Morelli, I.; Hamburger, M.; Hostetmann, K., Flavans and A-type proanthocyanidins from Prunus prostrata. Phytochemistry 1996, 43, 887-892; (b) Lin, H.-Y.; Kuo, Y.-H.; Lin, Y.-L.; Chiang, W., Antioxidative effect and active components from leaves of lotus (Nelumbo nucifera). Journal of Agricultural and Food Chemistry 2009, 57, 6623-6629. 57. Lin, G.; Chang, L.; Liu, Y.; Xiang, Z.; Chen, J.; Yang, Z., Enantioselective total syntheses of (+)-gallocatechin, (−)-epigallocatechin, and 8-C-ascorbyl-(−)-epigallo catechin. Chemistry–An Asian Journal 2013, 8, 700-704. 58. Saito, A.; Emoto, M.; Tanaka, A.; Doi, Y.; Shoji, K.; Mizushina, Y.; Ikawa, H.; Yoshida, H.; Matsuura, N.; Nakajima, N., Stereoselective synthesis of procyanidin B3-3-O-gallate and 3,3"-di-O-gallate, and their abilities as antioxidant and DNA polymerase inhibitor. Tetrahedron 2004, 60, 12043-12049. 59. (a) Choi, S.; Hong, Y.; Lee, B.; Park, J.; Jeong, H.; Kim, W.; Shin, S.; Yoon, K., Separation of polyphenols and caffeine from the acetone extract of fermented tea leaves (Camellia sinensis) using high-performance countercurrent chromatography. Molecules 2015, 20, 13216-13225; (b) Kim, H. J.; Lee, J. Y.; Kim, S. M.; Park, D.-A.; Jin, C.; Hong, S. P.; Lee, Y. S., A new epicatechin gallate and calpain inhibitory activity from Orostachys japonicus. Fitoterapia 2009, 80, 73-76. 60. Wilkins, C. K.; de Bruijn, J.; Korver, O.; Frost, D. J.; Weinges, K., Isolation and identification of (−)-gallocatechin gallate and circular dichroism of green tea flavanols. Journal of the Science of Food and Agriculture 1971, 22, 480-484. 61. Esatbeyoglu, T.; Juadjur, A.; Wray, V.; Winterhalter, P., Semisynthetic preparation and isolation of dimeric procyanidins B1–B8 from roasted hazelnut skins (Corylus avellana L.) on a large scale using countercurrent chromatography. Journal of Agricultural and Food Chemistry 2014, 62, 7101-7110. 62. Fujii, W.; Toda, K.; Kawaguchi, K.; Kawahara, S.-I.; Katoh, M.; Hattori, Y.; Fujii, H.; Makabe, H., Syntheses of prodelphinidin B3 and C2, and their antitumor activities through cell cycle arrest and caspase-3 activation. Tetrahedron 2013, 69, 3543-3550. 63. Petereit, F.; Kolodziej, H.; Nahrstedt, A., Flavan-3-ols and proanthocyanidins from Cistus incanus. Phytochemistry 1991, 30, 981-985. 64. Barrett, M. W.; Klyne, W.; Scopes, P. M.; Fletcher, A. C.; Porter, L. J.; Haslam, E., Plant proanthocyanidins. Part 6. Chiroptical studies. Part 95. Circular dichroism of procyanidins. Journal of the Chemical Society, Perkin Transactions 1 1979, 2375-2377. 65. Sun, D.; Wong, H.; Foo, L. Y., Proanthocyanidin dimers and polymers from Quercus dentata. Phytochemistry 1987, 26, 1825-1829. 66. Hashimoto, F.; Nonaka, G.-I.; Nishioka, I., Tannins and related compounds. XC. : 8-C-Ascorbyl (−)-epigallocatechin 3-O-gallate and novel dimeric flavan-3-ols, oolonghomobisflavans A and B, from oolong Tea. Chemical and Pharmaceutical Bulletin 1989, 37, 3255-3263. 67. Mamdouh, N. S.; Sugimoto, S.; Matsunami, K.; Otsuka, H.; Kamel, M. S., Taxiphyllin 6′-O-gallate, actinidioionoside 6′-O-gallate and myricetrin 2″-O-sulfate from the leaves of Syzygium samarangense and their biological activities. Chemical and Pharmaceutical Bulletin 2014, 62, 1013-1018. 68. (a) Otsuka, H.; Hirata, E.; Shinzato, T.; Takeda, Y., Stereochemistry of megastigmane glucosides from Glochidion zeylanicum and Alangium premnifolium. Phytochemistry 2003, 62, 763-768; (b) Sueyoshi, E.; Liu, H.; Matsunami, K.; Otsuka, H.; Shinzato, T.; Aramoto, M.; Takeda, Y., Bridelionosides A–F: megastigmane glucosides from Bridelia glauca f. balansae. Phytochemistry 2006, 67, 2483-2493. 69. Lou, J.; Chu, G.; Zhou, G.; Jiang, J.; Huang, F.; Xu, J.; Zheng, S.; Jiang, W.; Lu, Y.; Li, X.; Chen, Z.; He, J., Comparison between two kinds of cigarette smoke condensates (CSCs) of the cytogenotoxicity and protein expression in a human B-cell lymphoblastoid cell line using CCK-8 assay, comet assay and protein microarray. Mutation Research 2010, 697, 55-59.
|